Asymmetry in Atypical Parkinsonian Syndromes—A Review
Abstract Background/Objectives: Atypical parkinsonian syndromes (APSs) are a group of neurodegenerative disorders that differ from idiopathic Parkinson’s disease (IPD) in…
movement disorders
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
Abstract Movement disorders such as Parkinson’s disease and dyskinesia are highly debilitating conditions linked to oxidative stress and neurodegeneration. When…
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders
Abstract The discovery of endocannabinoid’s role within the central nervous system and its potential therapeutic benefits have brought forth rising…
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options
Abstract There are currently no disease-modifying treatments for progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD), and no approved pharmacological…
The Addenbrooke’s Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
Abstract Objective: Differentiating idiopathic Parkinson’s disease from atypical parkinsonian syndromes is challenging, especially in the early stages. We assessed whether…